ProEn Therapeutics Inc. announced that it has received funding from new investor Kolmar Korea Holdings Co., Ltd. on March 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,890 KRW | -3.16% | -4.72% | +12.53% |
May. 16 | Kolmar Holdings Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 06 | Kolmar Group Vice Chairman Appointed as CEO of Kolmar Holdings | MT |
1st Jan change | Capi. | |
---|---|---|
+12.53% | 238M | |
+11.97% | 8.05B | |
+8.98% | 7.96B | |
+3.48% | 6.12B | |
-5.53% | 3.73B | |
-12.16% | 3.51B | |
-13.23% | 1.19B | |
-27.20% | 1.12B | |
+13.13% | 975M | |
-13.39% | 828M |
- Stock Market
- Equities
- A024720 Stock
- News Kolmar Holdings Co.,Ltd.
- ProEn Therapeutics Inc. announced that it has received funding from Kolmar Korea Holdings Co., Ltd.